Enliven Therapeutics ELVN
NASDAQ ELVN
$41.81 +0.56 (+1.36%)
As of: Oct 21, 2026 · 3:59 PM EDT

Enliven Therapeutics (ELVN) Current Taxes (2024)

Updated

Enliven Therapeutics' Current Taxes came in at $232,000 for Q2 2024.

Analysis

Enliven Therapeutics (ELVN) Current Taxes (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.47 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 653.00 Mn
10 Enliven Therapeutics 2.77 Bn 482.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 232,000.00
API Access

Enliven Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=ELVN&period=max&api_key=YOUR_API_KEY